Nanollose Ltd (NC6)

Snapshot

NC6's Principal Activity is the research and development, and promotion of the Company�?s microbial cellulose technology. The primary focus has been directed towards the development, scale up and ultimate commercialisation of the Company�?s Plant-Free rayon fibre for use in textiles (nullarborTM) and non-woven applications (nufolium�?).

Announcements

Corporate Overview

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date	Amount	Franking	Gross	Type	Payable
No dividends paid.

Show All

See Upcoming Dividends for all ASX companies.

Directors & Management

Name	Title	Since	Bio
Ms Heidi Beatty	Non-Executive Director	Jul 2019	Ms Heidi Beatty Non-Executive Director Ms Beatty, founder of Crown Abbey Ltd is a scientist and innovator who has 20 years' experience developing consumer and health care products. She worked with Johnson & Johnson for 10 years in Europe and the US. In 2015 she founded Crown Abbey Ltd, a consultancy company that supports clients in their project launches, combining Project Management and Product Development across Consumer and Healthcare categories.
Mr Terence (Terry) Walsh	Non-Executive Director	Aug 2016	Mr Terence (Terry) Walsh Non-Executive Director Mr Walsh is a senior commercial lawyer and manager with more than 20 years of experience in project development, mining and general commercial law. He initially worked with leading law firms in Perth and Sydney before moving in house, where he has worked as the General Counsel of Hancock Prospecting Pty Ltd and prior to that as a Corporate Counsel with Rio Tinto Ltd. In these roles he has been involved with the legal and commercial aspects associated with the development and operation of technology and mining projects.
Dr Wayne Morris Best	Executive Chairman,Executive Director	Sep 2014	Dr Wayne Morris Best Executive Chairman,Executive Director Dr Best has 40 years' experience in organic chemistry both in academia, government and industry. He then spent two years at Imperial College in the UK where he obtained a DIC, followed by a year at the Australian National University in Canberra. He then took up a position with ICI Australia's Research Group in Melbourne for four and a half years which included a secondment to ICI Agrochemicals in the UK. Following ICI, he returned to Western Australia and spent ten years at the Chemistry Centre (WA) where he was responsible for the formation and running of the Medicinal & Biological Chemistry Section which undertook collaborative R&D into drug discovery and contract synthesis for the drug discovery and pharmaceutical industries. He then founded Epichem Pty Ltd, a contract research and drug discovery Company, which he managed for 14 years before moving full-time to Nanollose in 2018 He has served as a Director for several listed and unlisted biotechnology companies. He was a former director of Pharmaust Limited.
Mr Winton William Willesee	Non-Executive Director	Sep 2014	Mr Winton William Willesee Non-Executive Director Mr Willesee is an experienced company director and secretary with over 20 years' experience in various roles within the Australian capital markets. Mr Willesee has considerable experience with ASX listed and other companies over a broad range of industries having been involved with many successful ventures from early stage through to large capital development projects. He has a core expertise in strategy, company development, corporate governance, company public listings, merger and acquisition transactions and corporate finance
Ms Erlyn Dale	Company Secretary	N/A

Show All

Director Transactions

Date	Director	Type	Amount	Price	Value	Notes
14/01/21	Winton Willesee	Buy	+170,000	$0.083	$14,110	On-market trade
04/12/20	Raffaele (Alfie) Germano	Issued	2,000,000	$0.049	$98,000	Director remuneration
04/12/20	Raffaele (Alfie) Germano	Issued	146,796	$0.026	$3,750	Director remuneration
04/12/20	Raffaele (Alfie) Germano	Issued	500,000	$0.049	$24,500	Conversion of securities
04/12/20	Raffaele (Alfie) Germano	Exercise	500,000	$0.049	$24,500	Conversion of securities
04/12/20	Terence (Terry) Walsh	Issued	68,504	$0.026	$1,750	Director remuneration
04/12/20	Winton Willesee	Issued	68,504	$0.026	$1,750	Director remuneration
04/12/20	Heidi Beatty	Issued	500,000	$0.049	$24,500	Director remuneration
04/12/20	Heidi Beatty	Issued	68,504	$0.026	$1,750	Director remuneration
04/12/20	Wayne Best	Issued	2,000,000	$0.049	$98,000	Director remuneration
04/12/20	Wayne Best	Issued	146,796	$0.026	$3,750	Director remuneration
13/05/20	Winton Willesee	Issued	2,237,143	$0.024	$53,691	Rights issue
13/05/20	Wayne Best	Issued	2,367,144	$0.024	$56,811	Rights issue
13/05/20	Terence (Terry) Walsh	Issued	200,000	$0.024	$4,800	Rights issue
13/05/20	Raffaele (Alfie) Germano	Issued	200,000	$0.024	$4,800	Rights issue
20/11/19	Wayne Best	Issued	2,000,000	$0.071	$142,000	Issue of securities
20/11/19	Raffaele (Alfie) Germano	Issued	2,000,000	$0.071	$142,000	Issue of securities
02/05/19	Wayne Best	Buy	+100,000	$0.063	$6,320	On-market trade

Show All

Director Interests

Director	Last Notice	Direct Shares	Indirect Shares	Options	Convertibles
Heidi Beatty	30/06/2021	68,504	N/A	500,000	N/A
Terence (Terry) Walsh	30/06/2021	700,000	68,504	N/A	N/A
Wayne Best	30/06/2021	N/A	8,431,798	N/A	N/A
Winton Willesee	30/06/2021	N/A	8,068,504	N/A	N/A

Show All

Top 20 Shareholders

About the Data

Name	Shares	Capital
Wayne Morris Best <Wayne & Debra Best Fam A/C>	8,431,798	5.67%
Azalea Family Holdings Pty Ltd	8,000,000	5.38%
Mr Jason Duncan Maclaurin	6,351,190	4.27%
Mr John Moursounidis <Moursounidis Family A/C>	5,934,523	3.99%
Mrs Suzanne Margaret Cass <Cass A/C>	4,231,977	2.85%
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient Drp>	4,231,504	2.85%
Mr Jonathan James Hunter & Mrs Rebecca Mei Liang Hunter <Hhc Equities Superfund A/C>	3,280,000	2.21%
Citicorp Nominees Pty Limited	2,596,514	1.75%
Mr Michael Hilton Holbrook	2,361,470	1.59%
Tripit Pty Ltd <Peter Heather Wells S/F A/C>	2,060,000	1.39%
Madeiros Pty Ltd <Visser Super Fund A/C>	1,760,826	1.18%
10 Bolivianos Pty Ltd	1,694,834	1.14%
Mr Adam Laurence Bode	1,500,000	1.01%
Germano Mcinally Pty Ltd	1,346,796	0.91%
Mr Bill Chia-Han Chang	1,219,761	0.82%
Mr Andreas Steinwachs	1,184,111	0.80%
Mr David Robin Lunn & Mrs Stephanie Ann Yu <Lunn Superfund A/C>	1,074,729	0.72%
Mr Dean Anthony Mackenzie	1,001,000	0.67%
Vageli Panagiotidis	1,000,000	0.67%
Primaclass Consulting Pty Ltd <Primaclass Super Fund A/C>	1,000,000	0.67%
Mr Zhiyu Ning	900,000	0.61%

Show All

Shareholder Distribution

As reported in the most recent Annual Report.

Substantial Shareholders

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Share Price History

Date	Close	Change	%Chg	Open	High	Low	Volume	Turnover

Full Month

Historical Data

Year	Closing Price	Last Trade
2020	$0.04	30 June
2019	$0.047	28 June
2018	$0.13	29 June

NC6 Historical Price Data (CSV)

Up to 20 years of EOD share price history

Sign up to Download

You must be logged in to access this feature. Please sign up for free or login.